Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.
Gadani SP, Reyes-Mantilla M, Jank L, Harris S, Douglas M, Smith MD, Calabresi PA, Mowry EM, Fitzgerald KC, Bhargava P. Gadani SP, et al. Among authors: mowry em. medRxiv [Preprint]. 2021 Aug 25:2021.08.23.21262472. doi: 10.1101/2021.08.23.21262472. medRxiv. 2021. Update in: EBioMedicine. 2021 Nov;73:103636. doi: 10.1016/j.ebiom.2021.103636 PMID: 34462762 Free PMC article. Updated. Preprint.
A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS.
Newsome SD, Tian F, Shoemaker T, Fitzgerald KC, Cassard SD, Fiol J, Snoops S, Cooper DS, Mammen JSR, Bhargava P, Mowry EM, Calabresi PA. Newsome SD, et al. Among authors: mowry em. Neurotherapeutics. 2023 Sep;20(5):1263-1274. doi: 10.1007/s13311-023-01402-3. Epub 2023 Jul 17. Neurotherapeutics. 2023. PMID: 37460763 Free PMC article. Clinical Trial.
157 results